Clinical Trials Directory

Trials / Completed

CompletedNCT03862469

Premenstrual Hormonal and Affective State Evaluation (PHASE) Project

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
129 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).

Detailed description

Female volunteers will be recruited from the community for participation in this 3-menstrual cycle study. In the first two menstrual cycles, study participants will chart their symptoms and and ovulation. Study participants will continue to perform ovulation testing during their third menstrual cycle in which they will attend one individualized task session and provide 8 serum samples at different timepoints across the menstrual cycle. Primary analyses will contrast neuroactive hormone trajectories across the menstrual cycle and stress reactivity according to study groups (PMDD vs healthy).

Conditions

Interventions

TypeNameDescription
PROCEDUREIndividualized laboratory testLaboratory test administered between 6 and 2 days prior to the subsequent menstrual cycle.

Timeline

Start date
2019-09-26
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2019-03-05
Last updated
2025-04-24
Results posted
2025-04-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03862469. Inclusion in this directory is not an endorsement.